Cedar
Cedar raises $200M Series D at $3.2B valuation
Quick Facts
Cedar: Series D Funding Round
Cedar has successfully raised $200M in Series D funding, reaching a valuation of $3.2B.
Company Overview
Patient payment and engagement platform
Funding Details
The Series D round was led by Tiger Global, with participation from Andreessen Horowitz, Thrive Capital, Concord Health Partners, Sound Ventures.
Company Information
- Headquarters: 55 Water Street, New York, NY 10041
- Founded: 2016
- Employees: 600+
- Category: HealthTech
Investment
Cedar plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Tiger Global: Verified investor in Series D
- Andreessen Horowitz: Verified investor in Series D
- Thrive Capital: Verified investor in Series D
- Concord Health Partners: Verified investor in Series D
- Sound Ventures: Verified investor in Series D
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
